Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
Abstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essenti...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Immunity & Ageing |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12979-022-00295-8 |
_version_ | 1811297502110941184 |
---|---|
author | Bastian Robinson Baarz Thea Laurentius Jana Wolf Inga Wessels Leo Cornelius Bollheimer Lothar Rink |
author_facet | Bastian Robinson Baarz Thea Laurentius Jana Wolf Inga Wessels Leo Cornelius Bollheimer Lothar Rink |
author_sort | Bastian Robinson Baarz |
collection | DOAJ |
description | Abstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essential micronutrient zinc. Nevertheless, the molecular mechanisms underlying a zinc deficiency-induced decrease in IL-2 production have not yet been satisfactorily elucidated. Recent animal and in vitro data suggested that the transcription factor cAMP-responsive element modulator (CREM) $$\alpha$$ α plays a critical role in T cells´ disturbed IL-2 production in suboptimal zinc conditions. However, its role in the human aging process and the possibility of influencing this detrimental process by short-term zinc supplementation have not yet been evaluated. Results Comparing peripheral lymphocytes of 23 young and 31 elderly subjects with either high, intermediate, or deficient zinc status, we observed zinc-dependent regulation of the IL-2 production mediated by the transcription factor CREM $$\alpha$$ α . For the first time in humans, we report a mutual relationship between low zinc levels, high CREM $$\alpha$$ α expression, subsequent impaired IL-2 production, and vice versa. Remarkably, an average of only 6 days of in vivo zinc supplementation to zinc-deficient seniors was sufficient to rapidly improve zinc status, reverse CREM $$\alpha$$ α overexpression, and counteract subsequent low IL-2 production rates. Conclusions Our ex vivo and in vivo data identify zinc deficiency-mediated CREM $$\alpha$$ α overexpression as a key cellular mechanism underlying impaired IL-2 production in the elderly and point toward the use of zinc as a rapidly immune-enhancing add-on nutraceutical in geriatric therapy. Graphical abstract During the aging process, there is a progressive decrease in zinc status, which in turn leads to overexpression of the transcription factor CREM $$\mathrm{\alpha }$$ α in peripheral lymphocytes. CREMα is a negative regulator of the IL-2 gene, the overexpression of which dramatically limits adequate IL-2 production. This deleterious mechanism can be counteracted by short-term oral zinc administration, which can adjust IL-2 production in old, zinc-deficient individuals to a level similar to that of young adults. |
first_indexed | 2024-04-13T06:05:16Z |
format | Article |
id | doaj.art-81bb2ddacd444642ab05827915faf80f |
institution | Directory Open Access Journal |
issn | 1742-4933 |
language | English |
last_indexed | 2024-04-13T06:05:16Z |
publishDate | 2022-08-01 |
publisher | BMC |
record_format | Article |
series | Immunity & Ageing |
spelling | doaj.art-81bb2ddacd444642ab05827915faf80f2022-12-22T02:59:16ZengBMCImmunity & Ageing1742-49332022-08-0119111610.1186/s12979-022-00295-8Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppressionBastian Robinson Baarz0Thea Laurentius1Jana Wolf2Inga Wessels3Leo Cornelius Bollheimer4Lothar Rink5Institute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalDepartment of Geriatric Medicine, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalDepartment of Geriatric Medicine, Faculty of Medicine, RWTH Aachen University HospitalInstitute of Immunology, Faculty of Medicine, RWTH Aachen University HospitalAbstract Background Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essential micronutrient zinc. Nevertheless, the molecular mechanisms underlying a zinc deficiency-induced decrease in IL-2 production have not yet been satisfactorily elucidated. Recent animal and in vitro data suggested that the transcription factor cAMP-responsive element modulator (CREM) $$\alpha$$ α plays a critical role in T cells´ disturbed IL-2 production in suboptimal zinc conditions. However, its role in the human aging process and the possibility of influencing this detrimental process by short-term zinc supplementation have not yet been evaluated. Results Comparing peripheral lymphocytes of 23 young and 31 elderly subjects with either high, intermediate, or deficient zinc status, we observed zinc-dependent regulation of the IL-2 production mediated by the transcription factor CREM $$\alpha$$ α . For the first time in humans, we report a mutual relationship between low zinc levels, high CREM $$\alpha$$ α expression, subsequent impaired IL-2 production, and vice versa. Remarkably, an average of only 6 days of in vivo zinc supplementation to zinc-deficient seniors was sufficient to rapidly improve zinc status, reverse CREM $$\alpha$$ α overexpression, and counteract subsequent low IL-2 production rates. Conclusions Our ex vivo and in vivo data identify zinc deficiency-mediated CREM $$\alpha$$ α overexpression as a key cellular mechanism underlying impaired IL-2 production in the elderly and point toward the use of zinc as a rapidly immune-enhancing add-on nutraceutical in geriatric therapy. Graphical abstract During the aging process, there is a progressive decrease in zinc status, which in turn leads to overexpression of the transcription factor CREM $$\mathrm{\alpha }$$ α in peripheral lymphocytes. CREMα is a negative regulator of the IL-2 gene, the overexpression of which dramatically limits adequate IL-2 production. This deleterious mechanism can be counteracted by short-term oral zinc administration, which can adjust IL-2 production in old, zinc-deficient individuals to a level similar to that of young adults.https://doi.org/10.1186/s12979-022-00295-8AgingCytokinesInterleukin-2Dietary supplementsTrace elementZinc |
spellingShingle | Bastian Robinson Baarz Thea Laurentius Jana Wolf Inga Wessels Leo Cornelius Bollheimer Lothar Rink Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression Immunity & Ageing Aging Cytokines Interleukin-2 Dietary supplements Trace element Zinc |
title | Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression |
title_full | Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression |
title_fullStr | Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression |
title_full_unstemmed | Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression |
title_short | Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression |
title_sort | short term zinc supplementation of zinc deficient seniors counteracts cremα mediated il 2 suppression |
topic | Aging Cytokines Interleukin-2 Dietary supplements Trace element Zinc |
url | https://doi.org/10.1186/s12979-022-00295-8 |
work_keys_str_mv | AT bastianrobinsonbaarz shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression AT thealaurentius shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression AT janawolf shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression AT ingawessels shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression AT leocorneliusbollheimer shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression AT lotharrink shorttermzincsupplementationofzincdeficientseniorscounteractscremamediatedil2suppression |